Lymphomas with translocation of both MYC and BCL2, “double-hit lymphoma,” as well as cases with MYC and BCL2 co-expression, without underlying translocation, “double-expressing lymphoma,” have an adverse prognosis (39, 40). The gene discussed is BCL2; the disease is lymphoma.